Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function

Clinical trial NCT04993404 · COMPLETED

Trial details

NCT number: NCT04993404
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency Healthy Subjects

Start date: 2021-08-27
Primary completion: 2022-09-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.